novo nordisk mash - Search News

Order byBest matchMost fresh

News

Wegovy News Pushes Novo Nordisk Stock

· 1h · on MSN

Wegovy News Pushes Novo Nordisk Stock Higher

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

Continue reading

· 9h · on MSN

Novo Nordisk shares pop 5% after Wegovy receives U.S. approval for liver disease

PharmExec · 2h

Novo Nordisk’s Soar Grows Following Accelerated Approval of Wegovy for MASH and Liver Fibrosis

53m

Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

4h

Novo Nordisk stock soar 5% today: here’s why analysts are bullish

Novo Nordisk stock gains as FDA expands Wegovy use, while Ozempic price cut aims to boost access and defend market share.

4don MSN

Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forces

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

4d

The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results